Targeting LEF1-mediated epithelial-mesenchymal transition reverses lenvatinib resistance in hepatocellular carcinoma
Crossref DOI link: https://doi.org/10.1007/s10637-024-01426-2
Published Online: 2024-02-19
Published Print: 2024-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Li, Xinxiu
Su, Hongmeng
Tang, Wenqing
Shu, Shihui
Zhao, Luyu
Sun, Jinghan
Fan, Hong
Text and Data Mining valid from 2024-02-19
Version of Record valid from 2024-02-19
Article History
Received: 15 December 2023
Accepted: 30 January 2024
First Online: 19 February 2024
Declarations
:
: The authors declare no competing interests.